Chest Pain Symptoms Differences Between Diabetic Patients and Non
chestpaindm
1 other identifier
observational
50
1 country
1
Brief Summary
Cardiovascular disease is the most severe cause of death among all non-infectious diseases and accountable for 17.5 million deaths in the world. Heart mortality in patients with DM is frequently associated with prevalence silent ischemia, which is triggered by autonomic neuropathy, thereby decreasing the chest pain felt by them
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2025
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 26, 2024
CompletedFirst Posted
Study publicly available on registry
December 5, 2024
CompletedStudy Start
First participant enrolled
January 10, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2026
ExpectedDecember 6, 2024
December 1, 2024
9 months
July 26, 2024
December 4, 2024
Conditions
Outcome Measures
Primary Outcomes (3)
Hospital admission
1 day
Intensive Care Unit admission
One week
Mortality
One month
Study Arms (2)
non diabetic
diabetic
Eligibility Criteria
All cases admitted to ED who meet the eligibility criteria will be recruited in this study after obtaining an informed consent chest pain of DM and non-DM patients with the acute coronary syndrome
You may qualify if:
- i) Patients diagnosed with STEMI and NSTEMI ii) Both genders iii) above the age of 30 years iv) Patients with acute myocardial infarction with or without chest pain (angina) for 24 hours v) patients who are hemodynamically stable vi) patients without acute decompensated heart failure (ADHF) vii) patients without malignant arrhythmias viii) patients without in Acute Lung Oedem (ALO) condition ix) patients not using ventilator x) patient willing to and become respondents.
You may not qualify if:
- i) Patients with several complications, thereby making it impossible to interview them ii) patients who have never undergone CABG surgery iii) patients who refuse to be respondents
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Assiut university
Asyut, Asyut Governorate, 2063045, Egypt
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Essam El-dien M Abdullah, MD
Assiut University
- STUDY DIRECTOR
Zeinab Abd-Elatiff, MD
Ismailia Universiry
- STUDY DIRECTOR
Khalid Abdelbaky, MD
Assiut University
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- assiut hospital
Study Record Dates
First Submitted
July 26, 2024
First Posted
December 5, 2024
Study Start
January 10, 2025
Primary Completion
October 1, 2025
Study Completion (Estimated)
June 1, 2026
Last Updated
December 6, 2024
Record last verified: 2024-12
Data Sharing
- IPD Sharing
- Will not share